Table 1

Demographics and baseline characteristics of all included patients

CharacteristicAll patients (n=30)SARS-CoV-2 positive n=27
Died (n=7)Survived (n=20)P value
Age (median, range)64.5 (37–80)68.4 (64–73)60.5 (37–80)0.03
Female (n, %)8 (26.7)07 (35.0)0.14
Comorbidities, N (%)
 Hypertension13 (43.3)3 (42.9)8 (40.0)
 Ischaemic heart disease1 (3.3)01 (5.0)1.00
 Heart failure2 (6.7)01 (5.0)1.00
 Diabetes mellitus (all types)6 (20.0)1 (14.3)5 (25.0)1.00
 Cerebrovascular disease2 (6.7)1 (14.3)1 (5.0)0.46
 Chronic respiratory disease7 (23.3)1 (14.3)6 (30.0)0.63
 Chronic hepatological disease1 (3.3)00
 Chronic rheumatological disease3 (10.0)1 (14.3)2 (10.0)1.00
 Malignancy4 (13.3)1 (14.3)3 (15.0)1.00
Treatments, N (%)
 ITU admission22 (73.3)6 (85.7)14 (70.0)0.63
 Days on ITU*10.5 (12.1)9.0 (7.9)13.3 (10.1)0.32
 CPAP†9 (30.0)3 (42.9)4 (23.5)0.37
 Intubation and ventilation20 (66.7)6 (85.7)13 (65.)0.63
  • *Values in this row represent mean and SD.

  • †Data unavailable for three patients—all SARS-CoV-2 positive and in the survived group, N, therefore, is 17 in this group.

  • CPAP, continuous positive airway pressure.